These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 4029016)

  • 1. Renal clearance of temocillin in volunteers.
    Overbosch D; van Gulpen C; Mattie H
    Drugs; 1985; 29 Suppl 5():128-34. PubMed ID: 4029016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetics of temocillin in patients with normal and impaired renal function.
    Boelaert J; Daneels R; Schurgers M; Lambert AM; Van Landuyt HW; Mellows G; Wolf J; Swaisland AJ
    J Antimicrob Chemother; 1983 Apr; 11(4):349-56. PubMed ID: 6853404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The renal clearance of cefuroxime and ceftazidime and the effect of probenecid on their tubular excretion.
    Verhagen CA; Mattie H; Van Strijen E
    Br J Clin Pharmacol; 1994 Feb; 37(2):193-7. PubMed ID: 8186065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temocillin pharmacokinetics in normal and impaired renal function.
    Höffler D; Koeppe P
    Drugs; 1985; 29 Suppl 5():135-9. PubMed ID: 4029017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonlinear kinetics of the thiamine cation in humans: saturation of nonrenal clearance and tubular reabsorption.
    Weber W; Nitz M; Looby M
    J Pharmacokinet Biopharm; 1990 Dec; 18(6):501-23. PubMed ID: 2280348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary excretion of bile acids in cholestasis: evidence for renal tubular secretion in man.
    Corbett CL; Bartholomew TC; Billing BH; Summerfield JA
    Clin Sci (Lond); 1981 Dec; 61(6):773-80. PubMed ID: 7297039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Competitive inhibition of renal tubular secretion of gemifloxacin by probenecid.
    Landersdorfer CB; Kirkpatrick CM; Kinzig M; Bulitta JB; Holzgrabe U; Drusano GL; Sörgel F
    Antimicrob Agents Chemother; 2009 Sep; 53(9):3902-7. PubMed ID: 19564368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of temocillin biliary excretion and gallbladder bile concentration in healthy subjects.
    Maudgal DP; Lanzini A; Northfield TC; Bridges C; Joseph AE
    Drugs; 1985; 29 Suppl 5():146-50. PubMed ID: 4029019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of temocillin in volunteers.
    Hampel B; Feike M; Koeppe P; Lode H
    Drugs; 1985; 29 Suppl 5():99-102. PubMed ID: 4029032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of renal function and dialysis on temocillin pharmacokinetics.
    Boelaert J; Daneels R; Schurgers M; Mellows G; Swaisland AJ; Lambert AM; Van Landuyt HW
    Drugs; 1985; 29 Suppl 5():109-13. PubMed ID: 4029012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enantiomer-enantiomer interaction of a uricosuric antihypertensive diuretic (DBCA) in renal tubular secretion and stereoselective inhibition by probenecid in the cynomolgus monkey.
    Nakano M; Higaki K; Kawahara S
    Xenobiotica; 1993 May; 23(5):525-36. PubMed ID: 8342300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competitive inhibition of renal tubular secretion of ciprofloxacin and metabolite by probenecid.
    Landersdorfer CB; Kirkpatrick CM; Kinzig M; Bulitta JB; Holzgrabe U; Jaehde U; Reiter A; Naber KG; Rodamer M; Sörgel F
    Br J Clin Pharmacol; 2010 Feb; 69(2):167-78. PubMed ID: 20233180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of temocillin (BRL 17421) in subjects with normal and impaired renal function.
    Leroy A; Humbert G; Fillastre JP; Borsa F; Godin M
    J Antimicrob Chemother; 1983 Jul; 12(1):47-58. PubMed ID: 6619046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of temocillin after intravenous and intramuscular administration.
    Modr Z; Morávek J; Dvorácek K; Sechser T; Janků I; Krebs V
    Czech Med; 1986; 9(4):181-6. PubMed ID: 3102181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biliary concentrations of temocillin.
    Poston GJ; Greengrass A; Moryson CJ
    Drugs; 1985; 29 Suppl 5():140-5. PubMed ID: 4029018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal tubular secretion and reabsorption as factors in ochratoxicosis: effects of probenecid on nephrotoxicity.
    Stein AF; Phillips TD; Kubena LF; Harvey RB
    J Toxicol Environ Health; 1985; 16(3-4):593-605. PubMed ID: 4087321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coupling between renal tubular secretion and effect of bumetanide.
    Odlind B; Beermann B; Lindström B
    Clin Pharmacol Ther; 1983 Dec; 34(6):805-9. PubMed ID: 6641097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Saturation of the tubular excretion of beta-lactam antibiotics.
    Bins JW; Mattie H
    Br J Clin Pharmacol; 1988 Jan; 25(1):41-50. PubMed ID: 3370191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacokinetics of mezlocillin. Comparison with ampicillin and influence of probenecid (author's transl)].
    Verbist L; Tjandramaga TB; Verbesselt R; de Schepper PJ
    Nouv Presse Med; 1982 Feb; 11(5 Pt 2):347-52. PubMed ID: 6460974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of renal tubular transport of methotrexate by probenecid.
    Bourke RS; Chheda G; Bremer A; Watanabe O; Tower DB
    Cancer Res; 1975 Jan; 35(1):110-6. PubMed ID: 1109785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.